NEWS

Granted PDT/PCI projects 2021
Radforsk Investment Foundation has granted five research projects…

Innspill til Perspektivmeldingen
Oslo Cancer Cluster har uttalt seg om Perspektivmeldingen 2021.

Lytix Biopharma and UiT with exclusive agreement
Lytix Biopharma enters into an exclusive license agreement with the Arctic University of Norway (UiT).

Norwegian life science @ SXSW2021
We participated in the influential technology conference SXSW2021.

OCC Accelerator is here
OCC Accelerator will help start-ups in cancer innovation succeed.

Talking about cancer research and equality
Putting a spotlight on equality in cancer research

Experienced CEO joins Kongsberg Beam Technology
Kerstin Jakobsson wants to bring personalised health to proton therapy.

Fundraising on the school curriculum
Students learned about how to raise capital for a start-up company.

Unravelling the mysteries of cancer cells
Seahorse instrument helps researchers develop novel cell therapies.